Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Sees Significant Drop in Short Interest

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSCGet Free Report) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 1,207 shares, a decline of 94.0% from the April 15th total of 20,181 shares. Based on an average trading volume of 61,720 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Cardiac Biotech Solutions Trading Down 3.8%

Shares of OTCMKTS CBSC traded down $0.00 during midday trading on Monday, reaching $0.04. The company had a trading volume of 10,000 shares, compared to its average volume of 19,759. Cardiac Biotech Solutions has a one year low of $0.02 and a one year high of $0.08. The firm’s fifty day moving average price is $0.04 and its 200-day moving average price is $0.04.

About Cardiac Biotech Solutions

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Featured Articles

Receive News & Ratings for Cardiac Biotech Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiac Biotech Solutions and related companies with MarketBeat.com's FREE daily email newsletter.